International Severe Asthma Registry: Canadian Cohort
Recruiting now NCT04045587
Run by University of British Columbia · for 18 and older · All sexes
What this study is about
The International Severe Asthma Registry is a global initiative looking to ensure that the care of people with severe asthma will continue to improve by collecting detailed information about the health and treatment of as many people with the disease as possible. The study will gather anonymized longitudinal real-life data for participants with severe asthma for five years. The purpose of the registry is to track the progress of participants and determine how well they are responding to treatment. Medical research using data from the registry will give the investigators a better understanding of severe asthma and help the investigators develop and improve the care and treatment for severe asthma participants. The Canadian cohort of the registry will collect information from Canadian participants with severe asthma across seven different sites.
Who can join (things the study team will check)
✅ You may be able to join if…
- Participants 18 years or older
- Participants receiving treatment according to GINA Step 5 or uncontrolled in GINA Step 4 (uncontrolled is defined as having severe asthma symptoms or frequent exacerbations)
Where this trial is running
- University of Alberta, Edmonton, Alberta, Canada
- Synergy MD Specialty Group, Edmonton, Alberta, Canada
- University of British Columbia, Vancouver, British Columbia, Canada
- University of British Columbia, Vancouver, British Columbia, Canada
- Kingston General Hospital, Kingston, Ontario, Canada
- University of Western Ontario, London, Ontario, Canada
- The Ottawa Hospital, Ottawa, Ontario, Canada
- Inspiration Research Limited, Toronto, Ontario, Canada
- McGill University, Montreal, Quebec, Canada
- Université de Sherbrooke, Sherbrooke, Quebec, Canada
- Université Laval, Quebéc City, Quebéc, Canada
- University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Who to contact
Shelley Abercromby · (604) 875-4111 · Shelley.Abercromby@vch.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT04045587.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.